BioFire BioMérieux H1 Revenues Rise 7 Percent Growth in immunoassay business segment sales was offset by a decline in molecular biology sales, the firm said. Startup BioFlyte Detects Airborne SARS-CoV-2 Using BioFire FilmArray Premium BioFlyte has developed a system to collect pathogens from ambient air, detecting and identifying them using the FilmArray system from BioFire. CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance The EUAs for Gravity and Curative's tests were revoked because they are no longer used by the companies, while BioFire's test now has FDA clearance. BioFire Dx Receives First FDA Marketing Clearance for SARS-CoV-2 Respiratory Panel The test is the first COVID-19 assay to transition from Emergency Use Authorization to a cleared regulatory status. SARS-CoV-2 Mutations Present Unexpected Opportunities, Challenges for MDx Developers Premium Some tests that detect multiple SARS-CoV-2 genes are serendipitously signaling new viral variants while still effectively detecting infections. Dec 8, 2020 BioMérieux Coronavirus Test Gets FDA OK for Use With Pooled Samples Nov 6, 2020 Multiplex PCR Panels for Joint Infections on the Horizon Premium Oct 22, 2020 BioMérieux Q3 Revenues Increase 21 Percent Oct 6, 2020 BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization Aug 12, 2020 Traveler's Diarrhea Among Soldiers Linked to Gut Microbiome Changes Jul 9, 2020 BioMérieux Reports 62 Percent BioFire FilmArray Sales Growth in Preliminary Q2 Release May 19, 2020 BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases Premium May 4, 2020 BioMérieux's BioFire SARS-CoV-2 Respiratory Panel Wins FDA Emergency Use Authorization Apr 16, 2020 BioMérieux Reports 22 Percent Q1 Revenue Growth, Withdraws Full-Year Guidance Mar 24, 2020 BioMérieux Rapid Coronavirus Test Gets FDA Emergency Use Authorization Mar 20, 2020 Commercial Coronavirus Test Developers Tweak Timelines, EUA Plans in Light of Loosened FDA Guidance Mar 5, 2020 Coronavirus Dx Emergency Use Authorizations Progressing Rapidly Despite Criticism Feb 26, 2020 BioMérieux Reports 11 Percent Revenue Growth in Q4 Feb 11, 2020 Qiagen Readying Updated Respiratory Panel for Emergency Coronavirus Testing Jan 14, 2020 BioMérieux Submits 43-Target BCID2 Test to FDA Apr 30, 2019 Study of Luminex GI Panel in Children Reveals Salmonella Detection Issue Premium Apr 24, 2019 BioMérieux Q1 Revenues Up 8 Percent Feb 27, 2019 BioMérieux Reports 10 Percent Revenue Growth in Q4 Feb 6, 2019 AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests Jan 3, 2019 Diagnostic Stewardship Debate Over BioFire Meningitis-Encephalitis Panel Heats Up Premium Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.